POSSIBLE HAZARDS OF ORAL-CONTRACEPTIVE USE

被引：12

作者：

KANNEL, WB ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,EVANS RES FDN,DEPT MED,BOSTON,MA 02115

来源：

CIRCULATION | 1979年 / 60卷 / 03期

关键词：

D O I：

10.1161/01.CIR.60.3.490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：490 / 491

页数：2

共 29 条

[1]

AFOLAFI SK, 1975, THESIS LONDON

[2]

ANRELL M, 1966, LANCET, V1, P291

[3]

BERAL V, 1976, LANCET, V2, P1047

[4]

CUTTS JH, 1966, BRIT J EXP PATHOL, V47, P401

[5] FAMILIAL AND ACQUIRED TYPE-5 HYPERLIPOPROTEINEMIA [J].

FALLAT, RW ;

GLUECK, CJ .

ATHEROSCLEROSIS, 1976, 23 (01) :41-62

[6] HYPERTRIGLYCERIDEMIA DURING TREATMENT WITH ESTROGEN AND ORAL CONTRACEPTIVES - AN ALTERATION IN HEPATIC FUNCTION [J].

GERSHBERG, H ;

HULSE, M ;

JAVIER, Z .

OBSTETRICS AND GYNECOLOGY, 1968, 31 (02) :186-+

[7] GONADAL HORMONES AND TRIGLYCERIDES [J].

GLUECK, CJ ;

FALLAT, R .

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1974, 67 (07) :667-669

[8]

GORDON T, 1977, HYPERLIPIDEMIA DIAGN, P71

[9] STUDIES ON MECHANISM OF INCREASED PLASMA TRIGLYCERIDE LEVELS INDUCED BY ORAL CONTRACEPTIVES [J].

HAZZARD, WR ;

SPIGER, MJ ;

BAGDADE, JD ;

BIERMAN, EL .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (09) :471-&

[10]

HAZZARD WR, 1973, P INT C ENDOCRINOLOG, P1006

← 1 2 3 →